Cognition Therapeutics | 4:持股变动声明-董事 Kreis Leslie W.
Cognition Therapeutics | 4:持股变动声明-董事 Fletcher Aaron G.L.
Cognition Therapeutics | 4:持股变动声明-董事 Wallace Peggy
Cognition Therapeutics | 4:持股变动声明-董事 Khattar Jack A.
Cognition Therapeutics | 4:持股变动声明-董事 RICHSTONE ELLEN B
Cognition Therapeutics | 4:持股变动声明-董事 Monia Brett P
Cognition Therapeutics | 4:持股变动声明-高管 Doyle John Brendan
Cognition Therapeutics | 4:持股变动声明-高管 Ricciardi Lisa
Cognition Therapeutics | 4:持股变动声明-高管 Caggiano Anthony
Cognition Therapeutics | 4:持股变动声明-高管 Doyle John Brendan
Cognition Therapeutics | 4:持股变动声明-高管 Ricciardi Lisa
Cognition Therapeutics | 4:持股变动声明-高管 Caggiano Anthony
Cognition Therapeutics | 4:持股变动声明-高管 Ricciardi Lisa
Cognition Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-AIGH Capital Management, LLC(4.8%),Orin H(4.8%)
Cognition Therapeutics | SC 13G:超过5%持股股东披露文件-Pathstone Family Office, LLC 271957427(7.53%)
Cognition Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-BIOS CAPITAL MANAGEMENT, LP(19.4%),BIOS ADVISORS GP, LLC(19.4%)等
Cognition Therapeutics | 3:首次持股声明-董事 Bios Clinical Opportunity Fund, LP
Cognition Therapeutics | 4:持股变动声明-董事 Kreis Leslie W.
Cognition Therapeutics | 4:持股变动声明-董事 Fletcher Aaron G.L.
Cognition Therapeutics | 4:持股变动声明-董事 Kreis Leslie W.
暂无数据
暂无数据